Back to Results
First PageMeta Content
Telomeres / Gerontology / Stem cells / Ageing / DNA replication / Telomerase / Geron Corporation / Myelodysplastic syndrome / Acute myeloid leukemia / Janus kinase inhibitor / Lenalidomide / Myelofibrosis


Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016
Add to Reading List

Document Date: 2016-04-17 19:35:18

Open Document

File Size: 1,51 MB

Share Result on Facebook
UPDATE